Global MSI-H/dMMR Market By Treatment Type (Immune Checkpoint Inhibitors (ICIs) and Combination Therapy), By Stage (Early Stages (Stage I and II) and Advanced Stages (Stage III and IV)), By Indication (Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer and Others), By End-User (Hospitals, Oncology Clinics, Research Institutions, and Homecare), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Global MSI-H/dMMR Market Size is expected to be worth around US$ 93.4 Billion by 2034, from US$ 8.9 Billion in 2024, growing at a CAGR of 26.6% during the forecas...